The burden on diagnostic and research laboratories to provide reliable inactivation for biological specimens to allow for safe downstream processing is high during the coronavirus disease 2019 (COVID-19) pandemic. We provide safety data regarding commonly used chemical and physical inactivation procedures that verify their effectiveness against severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2).
CITATION STYLE
Haddock, E., Feldmann, F., Shupert, W. L., & Feldmann, H. (2021). Inactivation of SARS-CoV-2 Laboratory Specimens. American Journal of Tropical Medicine and Hygiene, 104(6), 2195–2198. https://doi.org/10.4269/ajtmh.21-0229
Mendeley helps you to discover research relevant for your work.